Internal medicine journal
-
Internal medicine journal · Aug 2020
Association between the introduction of a structured form and the quality of diabetes in pregnancy clinic care.
Pregnancy in women with pre-gestational types 1 (T1DM) and 2 (T2DM) diabetes mellitus can be a clinical challenge. This study assessed the association between introducing a structured diabetes in pregnancy proforma, on the quality of medical record documentation and pregnancy outcomes in women with T1DM and T2DM. ⋯ The quality of documentation improved significantly which is likely attributable to the implementation of the proforma. This study supports the use of structured documentation to reduce variation in care and potentially improve pregnancy outcomes.
-
Internal medicine journal · Aug 2020
Case ReportsBeneficial effect of awake prone position in hypoxaemic patients with COVID-19: case reports and literature review.
We hereby present two case reports of moderate coronavirus disease patients, suffering from profound hypoxaemia, further deteriorating later on. A schedule pre-planned awake prone position manoeuvres were executed during their hospital stay. Following this, the patients' saturation improved, later to be weaned from oxygen support. Paucity of evidence and data regarding this topic led us to review the concept of awake prone position.
-
Internal medicine journal · Aug 2020
Poor access to kidney disease management services in susceptible patient populations in rural Australia is associated with increased aeromedical retrievals for acute renal care.
Inequalities in access to renal services and acute care for rural and remote populations in Australia have been described but not quantified. ⋯ Aeromedical retrievals for acute care were from rural areas without regular access to renal disease prevention or management services.
-
Internal medicine journal · Aug 2020
Complementary medicine use and its cost in Australians with type 2 diabetes: The Fremantle Diabetes Study Phase II.
Few studies have examined complementary medicine (CM) use in diabetes. Australian data are inconsistent, limited in scope and have not considered cost. ⋯ CM use in type 2 diabetes is both common and costly. Healthcare professionals should consider discussing safe and cost-effective use of CM with their patients with type 2 diabetes.